Background: Predicting treatment outcome in major depressive disorder (MDD) remains an essential challenge for precision psychiatry. Clinical prediction models (CPMs) based on supervised machine learning have been a promising approach for this endeavor. However, only few CPMs have focused on model sparsity even though sparser models might facilitate the translation into clinical practice and lower the expenses of their application.Methods: In this study, we developed a predictive modeling pipeline that combines hyperparameter tuning and recursive feature elimination in a nested cross-validation framework. We applied this pipeline to a real-world clinical data set on MDD treatment response and to a second simulated data set using three diffe...
[[abstract]]This study aims to develop and validate the use of machine learning-based prediction mod...
Background: Major depressive disorder (MDD) is a highly prevalent, chronic and disabling condition. ...
Major depressive disorder (MDD) is a highly prevalent psychiatric disorder that affects millions of ...
BackgroundPredicting treatment outcome in major depressive disorder (MDD) remains an essential chall...
Improving response and remission rates in major depressive disorder (MDD) remains an important chall...
Objective: Despite a broad arsenal of antidepressants, about a third of patients suffering from majo...
Objective: The study objective was to generate a prediction model for treatment-resistant depression...
ObjectivesAntidepressants are first-line treatments for major depressive disorder (MDD), but 40-60% ...
Heterogeneity of major depressive disorder (MDD) illness course complicates clinical decision-making...
Backgrounds. Clinicians need guidance to address the heterogeneity of treatment responses of patient...
Background: Course of illness in major depression (MD) is highly varied, which might lead to both un...
Heterogeneity in the clinical presentation of major depressive disorder and response to antidepressa...
Background: Deep learning has utility in predicting differential antidepressant treatment response a...
The identification of generalizable treatment response classes (TRC[s]) in major depressive disorder...
[[abstract]]This study aims to develop and validate the use of machine learning-based prediction mod...
Background: Major depressive disorder (MDD) is a highly prevalent, chronic and disabling condition. ...
Major depressive disorder (MDD) is a highly prevalent psychiatric disorder that affects millions of ...
BackgroundPredicting treatment outcome in major depressive disorder (MDD) remains an essential chall...
Improving response and remission rates in major depressive disorder (MDD) remains an important chall...
Objective: Despite a broad arsenal of antidepressants, about a third of patients suffering from majo...
Objective: The study objective was to generate a prediction model for treatment-resistant depression...
ObjectivesAntidepressants are first-line treatments for major depressive disorder (MDD), but 40-60% ...
Heterogeneity of major depressive disorder (MDD) illness course complicates clinical decision-making...
Backgrounds. Clinicians need guidance to address the heterogeneity of treatment responses of patient...
Background: Course of illness in major depression (MD) is highly varied, which might lead to both un...
Heterogeneity in the clinical presentation of major depressive disorder and response to antidepressa...
Background: Deep learning has utility in predicting differential antidepressant treatment response a...
The identification of generalizable treatment response classes (TRC[s]) in major depressive disorder...
[[abstract]]This study aims to develop and validate the use of machine learning-based prediction mod...
Background: Major depressive disorder (MDD) is a highly prevalent, chronic and disabling condition. ...
Major depressive disorder (MDD) is a highly prevalent psychiatric disorder that affects millions of ...